<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Live birth rates are increased by treatment with <z:chebi fb="5" ids="28304">heparin</z:chebi> and aspirin in cases of poor pregnancy outcome such as <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Both drugs may attenuate <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> by inhibiting aberrant coagulation or by modulating trophoblast <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we assessed their roles in trophoblast <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>STUDY DESIGN: BeWo cells and placental villi were cultured in sera from women with successful or failing in vitro fertilization, with and without <z:chebi fb="5" ids="28304">heparin</z:chebi> or aspirin </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was assessed by using DNA laddering, cytokeratin 18 neoepitope formation, Bcl-2, and caspase 7 expression </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In BeWo cells, sera from in vitro fertilization failure increased trophoblast <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, whereas <z:chebi fb="5" ids="28304">heparin</z:chebi> and aspirin reversed these effects </plain></SENT>
<SENT sid="6" pm="."><plain>In villous trophoblast, <z:chebi fb="5" ids="28304">heparin</z:chebi> increased Bcl-2 and cytokeratin 18 protein expression </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> and aspirin inhibited DNA laddering </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: <z:chebi fb="5" ids="28304">Heparin</z:chebi> and aspirin modulate trophoblast <z:mpath ids='MPATH_3'>apoptosis</z:mpath> suggesting a direct impact on trophoblast biology, thus providing an additional mechanism to explain the clinical benefits of <z:chebi fb="5" ids="28304">heparin</z:chebi> and aspirin on recurrent pregnancy loss </plain></SENT>
</text></document>